echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Cardiovasc Diabetol: TyG Index as a Surrogate for Cardiovascular Risk Stratification in Cancer Survivors

    Cardiovasc Diabetol: TyG Index as a Surrogate for Cardiovascular Risk Stratification in Cancer Survivors

    • Last Update: 2022-05-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Thanks to advances in early diagnosis and cancer treatments, more and more cancers are surviving for a long time


    Cardiovascular disease (CVD) is the second most common cause of death among cancer survivors, after cancer deaths


    Prevention of cardiovascular disease is an important part of survival care for cancer survivors


    Patients with cancer who underwent routine health check-ups between 2009 and 2019 and who had survived more than 5 years as of January 1, 2011 and were followed up for hospitalization for cardiovascular disease (ischemic heart disease, stroke, or heart failure) were included.




    There was a graded positive correlation between TyG index and CVD hospitalization


    A 1-unit increase in the TyG index was associated with a 16% increase in the risk of CVD hospitalization and a 45% increase in the risk of acute myocardial infarction hospitalization


    The TyG index may serve as a simple surrogate for risk stratification of future cardiovascular disease events (especially atherosclerotic subtypes) in cancer survivors


    Original source:

    Original source:

    Jung, MH.


    Jung, MH.
    , Yi, SW.
    , An, SJ et al.
    Associations between the triglyceride-glucose index and cardiovascular disease in over 150,000 cancer survivors: a population-based cohort study.
    Cardiovasc Diabetol 21, 52 (2022).
    https: //doi.
    org/10.
    1186/s12933-022-01490-z.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.